Silencing of miR-221 induces apoptosis and G2/M phase arrest and inhibits cellular proliferation by upregulating P53 and downregulating Bcl-2 in HCC cells, leading to increased OS, RFS, and PFS in patients. Here, BCL2 is linked to hepatocellular carcinoma.